Jeffrey L. Ives, Director at Cara Therapeutics, Inc. (CARA), sold 5,000 shares at $23.24 ($116K) on 2019-08-01, disclosed to the SEC on 2019-08-05.
Open-market sale of $116k CARA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.24 | 2,500 | $58K | 50.0% |
| 2 | $23.24 | 2,500 | $58K | 50.0% |
| Total | $23.24 avg | 5,000 | $116K | 100% |
| Filing → |
| CARA | SELL | 2021-11-16 | $262K | — | Filing → |
| CARA | SELL | 2021-06-07 | $33K | — | Filing → |
| CARA | SELL | 2020-11-24 | $39K | — | Filing → |